Fig. 1From: Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up studyKaplan–Meier estimates of total major adverse CV events in statin-treated group (green line) and non-statin-treated group (blue line), during the average follow-up of 8 yearsBack to article page